Black Global 5 LLC → Hepion Pharmaceuticals, Inc. CTRVP

The Reporting Persons acquired the securities for investment purposes. The Reporting Persons intends to review its investment in the Issuer on a continuing basis. Depending upon market conditions, the Issuer's business, financial condition, prospects, general economic conditions and other factors deemed relevant, the Reporting Persons may acquire additional securities of the Issuer, dispose of some or all of its securities, or maintain its current investment position. Except as described herein, the Reporting Persons do not presently have any plans or proposals that relate to or would result in any of the actions described in Items 4(a) through (j) of Item 4 of Schedule 13D.